Trials / Conditions / Choroidal Neovascularization (CNV)
Choroidal Neovascularization (CNV)
3 registered clinical trials studyying Choroidal Neovascularization (CNV).
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Assess the Efficacy/Safety of Intravitreal Ranibizumab in Patients With Vision Loss Due to Choroidal Neovascul NCT01840410 | Novartis Pharmaceuticals | Phase 3 |
| Terminated | A Study Of Early Markers Of Choroidal Neovascularization NCT00902785 | Pfizer | — |
| Terminated | An Open Label Trial to Investigate Macugen for the Preservation of Visual Function in Subjects With Neovascula NCT00327470 | Pfizer | Phase 4 |